
Momenta Pharmaceuticals (MNTA)
We couldn’t load this chart.
Some asset charts might currently not be supported. To try again, please refresh this page.
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Momenta Pharmaceuticals (MNTA) Stock
Start investing in Momenta Pharmaceuticals (MNTA)
About Momenta Pharmaceuticals (MNTA)
Market cap | $6.24B |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 3.28M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -24.70x |
Today's range | — |
Debt / equity | — |
52 week range | $12.58 - $52.53 |
5 year debt / equity | 1.51x |
Beta (LTM) | 1.42x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Aug 10, 2020 |
Dividend payable date | — |
Momenta Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy MNTA stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in MNTA stock
Navigate to the Explore page. Then, type MNTA into the search bar. When you see MNTA stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased MNTA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Momenta Pharmaceuticals Stock Earnings
The value each MNTA share was expected to gain vs. the value that each MNTA share actually gained.
Momenta Pharmaceuticals (MNTA) reported Q2 2020 earnings per share (EPS) of -$0.48, missing estimates of -$0.39 by 23.08%. In the same quarter last year, Momenta Pharmaceuticals's earnings per share (EPS) was $0. Momenta Pharmaceuticals is expected to release next earnings on 08/10/2020, with an earnings per share (EPS) estimate of $0.